فایل ورد (word) مقاله Use of Oral Antidiabetic Drugs (Metformin and Pioglitazone) in Diabetic Patients with Breast Cancer: How Does It Effect on Serum Hif-1 Alpha and 8Ohdg Levels?

    —         —    

ارتباط با ما     —     لیست پایان‌نامه‌ها

... دانلود ...

 فایل ورد (word) مقاله Use of Oral Antidiabetic Drugs (Metformin and Pioglitazone) in Diabetic Patients with Breast Cancer: How Does It Effect on Serum Hif-1 Alpha and 8Ohdg Levels? دارای 10 صفحه می باشد و دارای تنظیمات در microsoft word می باشد و آماده پرینت یا چاپ است

فایل ورد فایل ورد (word) مقاله Use of Oral Antidiabetic Drugs (Metformin and Pioglitazone) in Diabetic Patients with Breast Cancer: How Does It Effect on Serum Hif-1 Alpha and 8Ohdg Levels?  کاملا فرمت بندی و تنظیم شده در استاندارد دانشگاه  و مراکز دولتی می باشد.

توجه : در صورت  مشاهده  بهم ريختگي احتمالي در متون زير ،دليل ان کپي کردن اين مطالب از داخل فایل ورد مي باشد و در فايل اصلي فایل ورد (word) مقاله Use of Oral Antidiabetic Drugs (Metformin and Pioglitazone) in Diabetic Patients with Breast Cancer: How Does It Effect on Serum Hif-1 Alpha and 8Ohdg Levels?،به هيچ وجه بهم ريختگي وجود ندارد


بخشی از متن فایل ورد (word) مقاله Use of Oral Antidiabetic Drugs (Metformin and Pioglitazone) in Diabetic Patients with Breast Cancer: How Does It Effect on Serum Hif-1 Alpha and 8Ohdg Levels? :


سال انتشار : 2012

تعداد صفحات :10

Objective: The aim was to investigate indicators related to DNA damage and cancer pathogenesis in Type IIdiabetes cases with breast cancer. It was planned to evaluate the relationship between these markers with oralantidiabetic drugs. Research Design and Methods: Fourty patients and 10 healthy individuals were included inthe study. HIF-1 and 8-OHdG are examined in blood samples taken from these individuals with an ELISA Kit.Statistical analysis of data was performed with 95% confidence using Windows package program SPSS 15.0.Results: HIF-1 parameters were found to be meaningfully higher in the patient group than the controls in bothpretreatment and posttreatment periods (p<0.05). No significant differences in terms of 8-OHdG between patientsand controls. However, posttreatment serum HIF-1 ve 8-OHdG levels was found lower than pretreatmentlevels in patients receiving metformin, but not with pioglitazone. Conversely, serum 8-OHdG levels decreasedsignificantly in these patients. When patients were evaluated according to the treatment groups (pioglitazone vs.metfformin) no significant differences in terms of serum HIF-1 and 8-OHdG levels between treatment groups.Conclusions: HIF-1 levels decreased significantly in the patient group receiving metformin. However, therewas no significant difference in terms of HIF-1 levels in the patients receiving pioglitazone.

لینک کمکی